Revolution Medicines (RVMD) Deferred Taxes (2020 - 2024)
Revolution Medicines (RVMD) recorded quarterly Deferred Taxes of $762000.0 in Q4 2024, up 1672.09% quarter-over-quarter from $43000.0 in Q4 2023, and up 1672.09% on a YoY basis from $43000.0 in Q1 2024.
Revolution Medicines (RVMD) Deferred Taxes (2020 - 2024) Analysis & Trends
Revolution Medicines' Deferred Taxes history runs 4 years deep, the most recent figure standing at $762000.0 for Q4 2024.
- In Q4 2024, Deferred Taxes rose 1672.09% year-over-year to $762000.0; the TTM figure through Dec 2024 stood at $928000.0 (up 580.83% YoY), while the FY2024 annual figure was $762000.0, down 80.51% from the prior year.
- Deferred Taxes was $762000.0 for Q4 2024 at Revolution Medicines, up from $43000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $762000.0 in Q4 2024 to a low of -$359000.0 in Q4 2020.
- Historically, Deferred Taxes has averaged $217166.7 across 4 years, with a median of $83000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Deferred Taxes tumbled 65.04% in 2023, then surged 1672.09% in 2024.
- A 4-year view of Deferred Taxes shows it stood at -$359000.0 in 2020, then surged by 134.26% to $123000.0 in 2022, then sank by 65.04% to $43000.0 in 2023, then soared by 1672.09% to $762000.0 in 2024.
- The last three Deferred Taxes figures came in at $762000.0 (Q4 2024), $43000.0 (Q4 2023), and $123000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Revolution Medicines | 32.33 Bn | 32.33 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 762,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Dec 31, 2020 | -359,000.00 |
| Jun 30, 2020 | 18,000.00 |
| Mar 31, 2020 | 716,000.00 |